1/15
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
The Eukaryotic Cell Cycle
Cell division occurs in nearly every tissue during development: Specific events required to ensure every cell had everything it needs to live
After passing M phase and into G1, a cell can either continue through another division or enters G0; The cell cycle has major checkpoints where the cell cycle stops to make sure everything is good before continuing
Differentiated cells stop dividing and enter the G0 phase = quiescent
Quiescent: Temporary G0 state, the cell can enter G1 again if it is signaled to
Senescence: The cell is in a permanent G0 state; it can no longer enter G1
Unregulated cellular division leads to cancer development

Mammary Gland Development (Not on exam; an example of G0 → replication)
Mammary gland development is primarily post-natal:
The ductal tree develops as an invagnication of ectoderm
At birth, a rudimentary “ductal tree” structure is already present
Very limited development occurs until the onset of puberty
Majority of development occurs in utero; this is an example of development outside utero/during puberty

Signals and Receptors
Protein signaling molecules require a cell membrane receptor (Causes secondary signaling to occur)
Hydrophobic signaling molecules, such as steroid hormones, use nuclear receptors (Binds to ligand and goes through the plasma membrane/No secondary signaling molecule required)
A cell that is growing to divide experiences many changes:
Altered gene expression
Increased translation
Increased nutrient uptake and metabolic rate
Altered morphology

Nuclear Hormone Receptor: ER (Mammary gland development); What drug treats high estrogen in breast cancer cells
During puberty cells with estrogen binding receptors respond to increase in estrogen
Ex. Mammary epithelial cells on ductal tree lining
Estrogen passively diffuses through plasma membrane and binds to estrogen receptor in cytoplasm
Estrogen binding induces estrogen receptor (ER) dimerization
Receptor is then translocated to the nucleus
Binds to genes containing an estrogen response element (ERE)
ER interacts with coactivator proteins for the recruitment of transcription machinery
ER effects in combination with other transcription factors determines the levels expression for each gene in the cell
Tamoxifen: Estrogen antagonist competes with estrogen for binding to ER, stops dimerization from occurring

RAS-Dependent Pathway Activation/Deactivation
Peptide binding to RTKs (receptor tyrosine kinases) stimulates autophosphorylation; GRB2 bind phosphotyrosines; SOS is a guanine nucleotide exchange factor (GEF)
SOS activity results in GDP/GTP exchange by RAS; in a non-dividing cell RAS is an GDP-bound state; “active” RAS activates a signaling cascade for cell growth
RAS signaling is turned off by GTPase activating protein (GAP)
GTP → GDP + Pi
3rd phosphate in GTP binds to structure and allows function; when this P loop is hydrolyzed, the protein is no longer held up and is deactivated

RAS-Dependent Pathway
Protein
Pathway is activated by RTKs for many growth factors, such as IGF-1, EGF and PDGF
RAS-GTP interacts with RAF activating its protein kinase activity:
RAF phosphorylates MEK
MEK phosphorylates ERK
ERK phosphorylates transcription factors in the nucleus
ELK-1 binds Serum Response Element (SRE) located in pro-growth genes to activate their transcription; FOS is one of these genes
Sequential activation of protein kinases results in signal amplification and diversification, also known as a Signaling cascade
Phosphorylation and activity of target proteins reversed by protein phosphatases (Dephosphorylation)


Activating Protein-1
JUN and FOS = Activating protein-1 (AP-1)
This heterodimer is a very strong activator for the cell cycle
Transcriptional activator; binds TRE cis-acting element; regulates many genes needed for progression through cell cycle
One of the proteins resulting the AP-1 cascade is Cyclin D, an official signal that we are in G1

Myc/Max is Activator of Proliferation Genes
Mad/Max is a repressor of pro-growth genes (Recruits HDACs to close chromatin structure)
When AP1 is produced, it first results in MYC production; Myc competes with Mad for Max
Myc/Max complex is an activator of many pro-growth genes
i.e. cyclin D, cyclin E, E2F, PCNA, DNA pol ⍺ and stimulates RNA Pol II activity
The upregulation of cyclin D gene transcription by AP-1 and Myc “kick starts” the cell cycle

Cyclin-CDK Complex; Specific Cyclins and Their Respective Checkpoints; How are they regulated?
A family of kinases that controls cell cycle timing
Each active kinase has 2 subunits:
One catalytic subunit with a cyclin-dependent kinase (CDK)
CDK4, CDK6, CDK2, and CDK1
One regulatory subunit that requires cyclin
cyclin D, cyclin E, cyclin A, cyclin B
Specific Cyclins and their respective checkpoints:
Cyclin D-CDK4-6 → G1
Cyclin E-CDK2 → Restriction point (to enter S)
Cyclin A-CDK2 → S
Cyclin B/-CDK1 → M/Mitosis
Oscillation of Cyclin-CDK activity are the result of:
CDK phosphorylation or dephosphorylation
Controlled degradation of the cyclin subunit via ubiquitin (Ubiquitination)
Periodic synthesis of CDKs and cyclins
The action of specific CDK-inhibiting proteins (CIP)

CDK Regulation by Phosphorylation and Proteolysis
Ubiquitin = Regulatory protein that targets proteins for destruction
Proteasomes = Proteolytic enzyme complexes
DBRP = Destruction box recognizing protein

Cell Cycle Checkpoints
Restriction point: Checkpoint before DNA replication (Between G1 and S); If a cell passes this point, it is committed to S phase and cellular division
At this point cyclin-dependent kinase activity inhibitors are expressed in G1 termed CDK inhibitors (CKI)
Inhibitor of cdk4 (INK4) proteins bind to CDK4/6 in 1:1 stoichiometry, blocking cyclin D binding; (Ex, p16INK4a and p14ARF)
CDK interacting protein (CIP) binds to and inhibits the activities of intact (Active) CDK-cyclin complexes; (Ex, p21 and p27)
Overall works to inhibit S phase/cellular division

Restriction Point
Retinoblastoma protein (pRb): Corepressor that binds the activator E2F to arrest/stop cell division; Also recruits HDACs
Cyclin D-CDK4/6 and cyclin E-CDK2 both hyperphosphorylates Rb, releasing Rb from E2F
E2F is an activator of genes needed in S phase like:
Cell cycle machinery genes (cyclins, cyclin-dependent kinases)
pro-growth transcription factors (Myc, E2F family)
component of the DNA replication machinery (replisome) and chromatin proteins (histones)

Restriction Point Specific in Blocking Progress When DNA Damage is Detected
When DNA is damaged, p53 is activated and upregulates transcription of CKI genes (i.e. p21), which blocks CDK from binding ATP
p53 also upregulates cell cycle arrest proteins and DNA repair proteins
If damage cannot be repaired, p53 activates senescence
If the cell is unviable p53 activates apoptosis pathway

Retinoblastoma
Mutation in RB1 gene inactivates retinoblastoma protein (pRb) function/production, a key regulator of G1/S checkpoint
pRb typically inhibits E2F transcription, preventing early entry to the S phase
This loss of cell cycle control results in excessive proliferation and tumor formation (Because cells no longer stops to fix DNA damage)
Two-hit hypothesis: A defective allele is inherited and the second is lost through somatic mutation

G1 → S Phase Transition
Synthesis of cyclin A is required to transition to the S phase; E2F is a transcriptional activator of cyclin A
Requires enough active cyclin E-CDK2 to activate cyclin A-CDK2
This is because cyclin E-CDK2 is required for the cyclin E-CDK2-dependent destruction of cyclinA/cdk2 inhibitor Sic1
E-CDK2 phosphorylates Sic1, making it susceptible to ubiquitin ligase → ubiquitin-mediated degradation

How Does Cyclin A-CDK2 Relate to Licensing Coordination in DNA replication
Recall that the ORC binds tightly to DNA in G1
Regulating complexes Cdc6 and Cdt1 stops replication from occurring
In S phase, Cyclin A-CDK2 phosphorylates these complexes (and MCM) to begin replication
